Michele M Schantz1, Carissa D Powers2, Rosemary L Schleicher2, Joseph M Betz3, Stephen A Wise4. 1. Chemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA. Electronic address: Michele.schantz@nist.gov. 2. Nutritional Biomarkers Branch/Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. 3. Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA. 4. Chemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA; Office of Dietary Supplements, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract
BACKGROUND: There are a large number of clinical studies focusing on the measurement of individual fatty acids in serum or plasma; however, few studies have focused on the interlaboratory comparisons of these measurements. The National Institutes of Standards and Technology (NIST), in collaboration with the National Institutes of Health Office of Dietary Supplements (NIH-ODS) and the Centers for Disease Control and Prevention (CDC), has initiated a quality assurance program for assessing and improving the comparability of individual fatty acid measurements in serum and plasma. METHODS: This is a performance-based study so participants are encouraged to use their laboratory's methods for the quantification of the individual fatty acids that they typically measure in the unknown serum or plasma samples along with a control material. The control materials used to date are SRM 1950 Metabolites in Human Plasma and SRM 2378 Fatty Acids in Frozen Human Serum. RESULTS: To date, two studies of the Fatty Acid Quality Assurance Program (FAQAP) have been completed with 11 and 14 participants, respectively. The agreement among the laboratories for individual fatty acids was within 20% for 70% of the data submitted. Laboratories were also requested to run triplicate analyses for each unknown sample. The precision of the individual laboratory data was generally good, with relative standard deviations <20%. CONCLUSIONS: The results from the first two exercises indicate the need for additional assessment of the comparability among laboratories doing these measurements. Future studies will be conducted with the goals of increasing the number of participating laboratories, increasing awareness of the need to use control materials, and improving the comparability among laboratories. Published by Elsevier B.V.
BACKGROUND: There are a large number of clinical studies focusing on the measurement of individual fatty acids in serum or plasma; however, few studies have focused on the interlaboratory comparisons of these measurements. The National Institutes of Standards and Technology (NIST), in collaboration with the National Institutes of Health Office of Dietary Supplements (NIH-ODS) and the Centers for Disease Control and Prevention (CDC), has initiated a quality assurance program for assessing and improving the comparability of individual fatty acid measurements in serum and plasma. METHODS: This is a performance-based study so participants are encouraged to use their laboratory's methods for the quantification of the individual fatty acids that they typically measure in the unknown serum or plasma samples along with a control material. The control materials used to date are SRM 1950 Metabolites in Human Plasma and SRM 2378 Fatty Acids in Frozen Human Serum. RESULTS: To date, two studies of the Fatty Acid Quality Assurance Program (FAQAP) have been completed with 11 and 14 participants, respectively. The agreement among the laboratories for individual fatty acids was within 20% for 70% of the data submitted. Laboratories were also requested to run triplicate analyses for each unknown sample. The precision of the individual laboratory data was generally good, with relative standard deviations <20%. CONCLUSIONS: The results from the first two exercises indicate the need for additional assessment of the comparability among laboratories doing these measurements. Future studies will be conducted with the goals of increasing the number of participating laboratories, increasing awareness of the need to use control materials, and improving the comparability among laboratories. Published by Elsevier B.V.
Authors: D L Duewer; J B Thomas; M C Kline; W A MacCrehan; R Schaffer; K E Sharpless; W E May; J A Crowell Journal: Anal Chem Date: 1997-04-01 Impact factor: 6.986
Authors: Shuvro Roy; Theodore M Brasky; Martha A Belury; Shiva Krishnan; Rachel M Cole; Catalin Marian; Lisa D Yee; Adana A Llanos; Jo L Freudenheim; Peter G Shields Journal: Int J Cancer Date: 2015-07-28 Impact factor: 7.396
Authors: Chia-Lung Wu; Deeptee Jain; Jenna N McNeill; Dianne Little; John A Anderson; Janet L Huebner; Virginia B Kraus; Ramona M Rodriguiz; William C Wetsel; Farshid Guilak Journal: Ann Rheum Dis Date: 2014-07-10 Impact factor: 19.103
Authors: Karen W Phinney; Guillaume Ballihaut; Mary Bedner; Brandi S Benford; Johanna E Camara; Steven J Christopher; W Clay Davis; Nathan G Dodder; Gauthier Eppe; Brian E Lang; Stephen E Long; Mark S Lowenthal; Elizabeth A McGaw; Karen E Murphy; Bryant C Nelson; Jocelyn L Prendergast; Jessica L Reiner; Catherine A Rimmer; Lane C Sander; Michele M Schantz; Katherine E Sharpless; Lorna T Sniegoski; Susan S-C Tai; Jeanice B Thomas; Thomas W Vetter; Michael J Welch; Stephen A Wise; Laura J Wood; William F Guthrie; Charles R Hagwood; Stefan D Leigh; James H Yen; Nien-Fan Zhang; Madhu Chaudhary-Webb; Huiping Chen; Zia Fazili; Donna J LaVoie; Leslie F McCoy; Shahzad S Momin; Neelima Paladugula; Elizabeth C Pendergrast; Christine M Pfeiffer; Carissa D Powers; Daniel Rabinowitz; Michael E Rybak; Rosemary L Schleicher; Bridgette M H Toombs; Mary Xu; Mindy Zhang; Arthur L Castle Journal: Anal Chem Date: 2013-12-03 Impact factor: 6.986
Authors: Bruce A Benner; Michele M Schantz; Carissa D Powers; Rosemary L Schleicher; Johanna E Camara; Katherine E Sharpless; James H Yen; Lorna T Sniegoski Journal: Anal Bioanal Chem Date: 2018-02-13 Impact factor: 4.142
Authors: Katrice A Lippa; Juan J Aristizabal-Henao; Richard D Beger; John A Bowden; Corey Broeckling; Chris Beecher; W Clay Davis; Warwick B Dunn; Roberto Flores; Royston Goodacre; Gonçalo J Gouveia; Amy C Harms; Thomas Hartung; Christina M Jones; Matthew R Lewis; Ioanna Ntai; Andrew J Percy; Dan Raftery; Tracey B Schock; Jinchun Sun; Georgios Theodoridis; Fariba Tayyari; Federico Torta; Candice Z Ulmer; Ian Wilson; Baljit K Ubhi Journal: Metabolomics Date: 2022-04-09 Impact factor: 4.747